Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kopp

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|January 19, 1995
Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor geneP Kopp, J van Sande, J Parma, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 1999
Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasiaC R Nogueira, L Q Nguyen, J R Coelho-Neto, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2011
Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsyR P Kopp, J K Parsons, J Shiau, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Phenocopies for deafness and goiter development in a large inbred Brazilian kindred with Pendred's syndrome associated with a novel mutation in the PDS geneP Kopp, O K Arseven, L Sabacan, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Urologic Oncology|April 4, 2020
Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinomaNicholas H Chakiryan, Ann Martinez Acevedo, Mark A Garzotto, et al.
Nature Communications|December 16, 2021
Epigenetic loss of heterogeneity from low to high grade localized prostate tumoursSebnem Ece Eksi, Alex Chitsazan, Zeynep Sayar, et al.
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts]P Batel, C Reynaud-Maurupt, P Lavignasse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2022
SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer DeathXiaoyu Song, Meng Ru, Zoe Steinsnyder, et al.
European Journal of Endocrinology|May 29, 2001
Clinical and molecular analysis of three Mexican families with Pendred's syndromeO Gonzalez Trevino, O Karamanoglu Arseven, C J Ceballos, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|January 19, 1995
Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor geneP Kopp, J van Sande, J Parma, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 1999
Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasiaC R Nogueira, L Q Nguyen, J R Coelho-Neto, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2011
Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsyR P Kopp, J K Parsons, J Shiau, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Phenocopies for deafness and goiter development in a large inbred Brazilian kindred with Pendred's syndrome associated with a novel mutation in the PDS geneP Kopp, O K Arseven, L Sabacan, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Urologic Oncology|April 4, 2020
Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinomaNicholas H Chakiryan, Ann Martinez Acevedo, Mark A Garzotto, et al.
Nature Communications|December 16, 2021
Epigenetic loss of heterogeneity from low to high grade localized prostate tumoursSebnem Ece Eksi, Alex Chitsazan, Zeynep Sayar, et al.
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts]P Batel, C Reynaud-Maurupt, P Lavignasse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2022
SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer DeathXiaoyu Song, Meng Ru, Zoe Steinsnyder, et al.
European Journal of Endocrinology|May 29, 2001
Clinical and molecular analysis of three Mexican families with Pendred's syndromeO Gonzalez Trevino, O Karamanoglu Arseven, C J Ceballos, et al.
Pageof 22